Dr. Vishal Sawhney, MD

Dr. Sawhney practices at University Hospitals Portage Medical Center in Ravenna, Ohio, part of University Hospitals Health System.

Dr. Sawhney's NPI, 1164622247, was assigned on July 18, 2007. Dr. Sawhney holds Ohio license 35-090112.

Dr. Sawhney's primary practice is University Hospitals Portage Medical Center, at 6847 N Chestnut, Ravenna, OH 44266 in Portage County. The practice phone is (330) 297-2300.

Dr. Sawhney's primary practice is University Hospitals Portage Medical Center in Ravenna, Ohio, part of University Hospitals Health System. Dr. Sawhney is also affiliated with University Hospitals Cleveland Medical Center. The medical group on file is University Eyecare. Dmand AI also links Dr. Sawhney to 2 more hospitals, 3 medical groups, 1 physician office, 1 group practice or clinic and 1 hospital outpatient department, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Sawhney practices, 7 sites in all. Vendor and product names are available with a free account.

Pulmonary disease is Dr. Sawhney's primary specialty in the NPI Registry, under taxonomy code 207RP1001X. Dmand AI has Dr. Sawhney's licenses on file in 2 states: Ohio and Texas.

CMS data shows 818 Medicare services from Dr. Sawhney across 7 procedure codes in 2024, for 491 Medicare patients. Medicare paid $69,735 for them.

CMS counts 491 Medicare patients who saw Dr. Sawhney in 2024. The largest group is 65 to 74, with 221 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 10% are also on Medicaid. Their average risk score is 1.82, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Sawhney's median patient age at 72, with 53% women.

In 2024, Dr. Sawhney wrote 10,903 Medicare Part D claims for 1,221 patients. 65% of them were for generic drugs. CMS names the drug for 10,701 of them, across 59 drugs with 11 or more claims each, at $3,957,200 in total drug cost. In 2023, CMS named 11,236 claims across 60 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 91 out of 100 for Dr. Sawhney for performance year 2024, reported through an alternative payment model (APM). Dr. Sawhney accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Sawhney as offering telehealth.

Dmand AI links 1 paper to Dr. Sawhney in 2019. Dr. Sawhney's most frequent co-author is Amir Sharafkhaneh, MD, PhD.

CMS Open Payments shows 1,176 general payments to Dr. Sawhney from 56 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 82% of the total. Janssen Pharmaceuticals, Inc paid the most, $68,937.